Part II – Audience Questions
33:32 What about the timing of hydroxychloroquine use and for how long?
34:50 Should patients on bDMARDs or tsDMARDs (because of presumed risk) not go to work and should we write letters for such people?
37:05 Bush Administration disaster preparedness guidelines and supporting patients
39:06 What infusions should we not do? Denosumab? Zolendronic acid?
41:09 What to do about tocilizumab infusions being COVID diverted? What are the alternatives?
44:09 Should you start your lupus or RA patient on hydroxychloroquine or a new biologic in this era?
46:58 A patient has a resolved COVID-19 infection, would you start a biologic if needed?
47:21 Is anyone worried about the cardiotoxicity of hydroxychloroquine or chloroquine?
48:42 Would you the doctor, self-medicate, or prophylax, with HCQ if you have new onset suspicious symptoms?
50:04 Should rheumatologists do inpatient consults during the COVID?
51:30 If tests were universally available, would you test all your rheumatology patients for COVID-19?